ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment
NCT05414552
·
clinicaltrials.gov ↗
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class
Conditions
Immune Related Adverse Events
Colitis
Hepatitis
Dermatitis
Interventions
DRUG:
ECP
Sponsor
University of Freiburg